Weeks 5-8: acceleration phase Most protocols increase the dose at week 4 or 5
Outsourcing economics are the second driver
Schneider P, Weber-Fahr W, Schweinfurth N, Ho YJ, Sartorius A, Spanagel R, et al
Creatinine levels provide insight into kidney filtration, while eGFR estimates how well kidneys are functioning overall
[1] [11] Reevaluation at three- to six-month intervals allows clinicians to ascertain whether the dose can be reduced or the injection interval extended, reflecting current endocrine guidelines that emphasize the lowest effective estrogen exposure and periodic attempts at cessation once symptoms abate
If you see the same product for less elsewhere, we'll gladly try to match it